These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

928 related items for PubMed ID: 26927900

  • 21. Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency.
    Charles-Edwards G, Amaral N, Sleigh A, Ayis S, Catibog N, McDonagh T, Monaghan M, Amin-Youssef G, Kemp GJ, Shah AM, Okonko DO.
    Circulation; 2019 May 21; 139(21):2386-2398. PubMed ID: 30776909
    [Abstract] [Full Text] [Related]

  • 22. High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23.
    Dahlerup JF, Jacobsen BA, van der Woude J, Bark LÅ, Thomsen LL, Lindgren S.
    Scand J Gastroenterol; 2016 Nov 21; 51(11):1332-8. PubMed ID: 27326766
    [Abstract] [Full Text] [Related]

  • 23. Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside-1000 (Monofer® ) versus ferric carboxy-maltose (Ferinject® ). A single center, cohort study.
    Mulder MB, van den Hoek HL, Birnie E, van Tilburg AJP, Westerman EM.
    Br J Clin Pharmacol; 2019 Feb 21; 85(2):385-392. PubMed ID: 30393904
    [Abstract] [Full Text] [Related]

  • 24. Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency.
    Reed BN, Blair EA, Thudium EM, Waters SB, Sueta CA, Jensen BC, Rodgers JE.
    Pharmacotherapy; 2015 Jan 21; 35(1):64-71. PubMed ID: 25556867
    [Abstract] [Full Text] [Related]

  • 25. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy.
    al-Momen AK, al-Meshari A, al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, Abbas M.
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov 21; 69(2):121-4. PubMed ID: 8902444
    [Abstract] [Full Text] [Related]

  • 26. Treatment of iron deficiency in patients with chronic kidney disease: A prospective observational study of iron isomaltoside (NIMO Scandinavia)
.
    Jensen G, Gøransson LG, Fernström A, Furuland H, Christensen JH.
    Clin Nephrol; 2019 Apr 21; 91(4):246-253. PubMed ID: 30614439
    [Abstract] [Full Text] [Related]

  • 27. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J.
    Am J Gastroenterol; 2005 Nov 21; 100(11):2503-9. PubMed ID: 16279906
    [Abstract] [Full Text] [Related]

  • 28. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
    Khalafallah AA, Hyppa A, Chuang A, Hanna F, Wilson E, Kwok C, Yan C, Gray Z, Mathew R, Falloon P, Dennis A, Pavlov T, Allen JC.
    Semin Hematol; 2018 Oct 21; 55(4):223-234. PubMed ID: 30502851
    [Abstract] [Full Text] [Related]

  • 29. A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial.
    Auerbach M, Henry D, Derman RJ, Achebe MM, Thomsen LL, Glaspy J.
    Am J Hematol; 2019 Sep 21; 94(9):1007-1014. PubMed ID: 31243803
    [Abstract] [Full Text] [Related]

  • 30. Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice.
    Stein J, Walper A, Klemm W, Farrag K, Aksan A, Dignass A.
    Scand J Gastroenterol; 2018 Sep 21; 53(9):1059-1065. PubMed ID: 30222479
    [Abstract] [Full Text] [Related]

  • 31. A prospective observational study of effectiveness and safety of iron isomaltoside in patients with chronic renal failure and iron deficiency anemia
.
    Biggar P, Leistikow F, Walper A.
    Clin Nephrol; 2016 Dec 21; 86 (2016)(12):310-318. PubMed ID: 27737531
    [Abstract] [Full Text] [Related]

  • 32. Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience.
    Jesus-Silva JA, Lamplugh A, Dhada S, Burton JO, Bhandari S.
    BMC Nephrol; 2020 Jun 03; 21(1):212. PubMed ID: 32493240
    [Abstract] [Full Text] [Related]

  • 33. Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
    Abdel-Razeq H, Abbasi S, Saadi I, Jaber R, Abdelelah H.
    Drug Des Devel Ther; 2013 Jun 03; 7():939-44. PubMed ID: 24039403
    [Abstract] [Full Text] [Related]

  • 34. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
    Onken JE, Bregman DB, Harrington RA, Morris D, Acs P, Akright B, Barish C, Bhaskar BS, Smith-Nguyen GN, Butcher A, Koch TA, Goodnough LT.
    Transfusion; 2014 Feb 03; 54(2):306-15. PubMed ID: 23772856
    [Abstract] [Full Text] [Related]

  • 35. A randomized trial of intravenous and oral iron in chronic kidney disease.
    Agarwal R, Kusek JW, Pappas MK.
    Kidney Int; 2015 Oct 03; 88(4):905-14. PubMed ID: 26083656
    [Abstract] [Full Text] [Related]

  • 36. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial.
    Kochhar PK, Kaundal A, Ghosh P.
    J Obstet Gynaecol Res; 2013 Feb 03; 39(2):504-10. PubMed ID: 22925176
    [Abstract] [Full Text] [Related]

  • 37. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
    Bhavi SB, Jaju PB.
    BMC Pregnancy Childbirth; 2017 May 08; 17(1):137. PubMed ID: 28482869
    [Abstract] [Full Text] [Related]

  • 38. Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients.
    Borstlap WAA, Buskens CJ, Tytgat KMAJ, Tuynman JB, Consten ECJ, Tolboom RC, Heuff G, van Geloven N, van Wagensveld BA, C A Wientjes CA, Gerhards MF, de Castro SMM, Jansen J, van der Ven AWH, van der Zaag E, Omloo JM, van Westreenen HL, Winter DC, Kennelly RP, Dijkgraaf MGW, Tanis PJ, Bemelman WA.
    BMC Surg; 2015 Jun 28; 15():78. PubMed ID: 26123286
    [Abstract] [Full Text] [Related]

  • 39. A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO).
    Mikhail AI, Schön S, Simon S, Brown C, Hegbrant JBA, Jensen G, Moore J, Lundberg LDI.
    BMC Nephrol; 2019 Jan 10; 20(1):13. PubMed ID: 30630452
    [Abstract] [Full Text] [Related]

  • 40. Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure.
    Ambrosy AP, von Haehling S, Kalra PR, Court E, Bhandari S, McDonagh T, Cleland JGF.
    Am J Cardiol; 2021 Aug 01; 152():138-145. PubMed ID: 34162484
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.